Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 334
6
Diseases
28
Unique genes
0.145
Avg. similarity score
Gingival diseases
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Gingival diseases
Embryonal carcinoma
Gingivitis
Hodgkin disease
Hyaline fibromatosis
Prostatic hyperplasia
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Gingival diseases | 4 | 4 | 7 |
| Embryonal carcinoma | 3 | 3 | 2 |
| Gingivitis | 3 | 3 | 1 |
| Hodgkin disease | 2 | 2 | 17 |
| Hyaline fibromatosis | 1 | 1 | 1 |
| Prostatic hyperplasia | 1 | 1 | 7 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| TNFRSF8 | 4 / 6 | Embryonal carcinoma, Gingival diseases, Gingivitis, Hodgkin disease |
| ANTXR2 | 2 / 6 | Gingival diseases, Hyaline fibromatosis |
| FGF7 | 2 / 6 | Gingival diseases, Prostatic hyperplasia |
| PDGFB | 2 / 6 | Gingival diseases, Prostatic hyperplasia |
| TNFSF8 | 2 / 6 | Embryonal carcinoma, Hodgkin disease |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Prostate cancer | KEGG | 7 / 98 | 30.6× | 2.00e-9 | 2.05e-7 ✓ sig. |
| NF-kappa B signaling pathway | KEGG | 5 / 105 | 20.4× | 3.89e-6 | 1.55e-4 ✓ sig. |
| Growth hormone receptor signaling | Reactome | 3 / 14 | 91.9× | 4.06e-6 | 1.60e-4 ✓ sig. |
| Cytokine-cytokine receptor interaction | KEGG | 7 / 298 | 10.1× | 4.08e-6 | 1.61e-4 ✓ sig. |
| Malaria | KEGG | 4 / 50 | 34.3× | 5.06e-6 | 1.92e-4 ✓ sig. |
| Lipid and atherosclerosis | KEGG | 6 / 216 | 11.9× | 8.54e-6 | 2.94e-4 ✓ sig. |
| PI3K-Akt signaling pathway | KEGG | 7 / 361 | 8.3× | 1.44e-5 | 4.52e-4 ✓ sig. |
| Melanoma | KEGG | 4 / 73 | 23.5× | 2.30e-5 | 6.70e-4 ✓ sig. |
| Kaposi sarcoma-associated herpesvirus infection | KEGG | 5 / 196 | 10.9× | 7.97e-5 | 1.86e-3 ✓ sig. |
| Toll-like receptor signaling pathway | KEGG | 4 / 109 | 15.7× | 1.11e-4 | 2.44e-3 ✓ sig. |
| Rap1 signaling pathway | KEGG | 5 / 211 | 10.2× | 1.13e-4 | 2.47e-3 ✓ sig. |
| Toxoplasmosis | KEGG | 4 / 112 | 15.3× | 1.23e-4 | 2.66e-3 ✓ sig. |
| TNF signaling pathway | KEGG | 4 / 119 | 14.4× | 1.56e-4 | 3.21e-3 ✓ sig. |
| Pathways in cancer | KEGG | 7 / 533 | 5.6× | 1.71e-4 | 3.45e-3 ✓ sig. |
| Interleukin-10 signaling | Reactome | 3 / 47 | 27.4× | 1.72e-4 | 3.47e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| positive regulation of glomerular mesangial cell proliferation | GO:0072126 | 3 / 6 | 334× | 6.01e-8 | 7.91e-6 ✓ sig. |
| response to nutrient levels | GO:0031667 | 5 / 79 | 42.2× | 1.08e-7 | 1.29e-5 ✓ sig. |
| inflammatory response | GO:0006954 | 7 / 467 | 10.0× | 4.37e-6 | 2.69e-4 ✓ sig. |
| cellular response to platelet-derived growth factor stimulus | GO:0036120 | 3 / 26 | 77.0× | 7.65e-6 | 4.23e-4 ✓ sig. |
| positive regulation of endothelial cell apoptotic process | GO:2000353 | 3 / 29 | 69.0× | 1.07e-5 | 5.50e-4 ✓ sig. |
| response to follicle-stimulating hormone | GO:0032354 | 2 / 4 | 334× | 1.30e-5 | 6.40e-4 ✓ sig. |
| cellular response to insulin stimulus | GO:0032869 | 4 / 102 | 26.2× | 1.55e-5 | 7.38e-4 ✓ sig. |
| response to exogenous dsRNA | GO:0043330 | 3 / 34 | 58.9× | 1.75e-5 | 8.06e-4 ✓ sig. |
| cellular response to tumor necrosis factor | GO:0071356 | 4 / 107 | 24.9× | 1.87e-5 | 8.50e-4 ✓ sig. |
| response to testosterone | GO:0033574 | 3 / 36 | 55.6× | 2.08e-5 | 9.26e-4 ✓ sig. |
| positive regulation of canonical NF-kappaB signal transduction | GO:0043123 | 5 / 232 | 14.4× | 2.20e-5 | 9.66e-4 ✓ sig. |
| signaling | GO:0023052 | 3 / 42 | 47.7× | 3.33e-5 | 1.32e-3 ✓ sig. |
| female genitalia development | GO:0030540 | 2 / 7 | 191× | 4.53e-5 | 1.67e-3 ✓ sig. |
| positive regulation of cell division | GO:0051781 | 3 / 48 | 41.7× | 4.98e-5 | 1.79e-3 ✓ sig. |
| cellular response to cytokine stimulus | GO:0071345 | 3 / 53 | 37.8× | 6.71e-5 | 2.24e-3 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Embryonal carcinoma | Hodgkin disease | 0.111 | 2 | 1.15e-6 | 7.04e-6 ✓ sig. |
| Gingival diseases | Prostatic hyperplasia | 0.154 | 2 | 3.72e-6 | 2.09e-5 ✓ sig. |
| Embryonal carcinoma | Gingivitis | 0.333 | 1 | 1.30e-4 | 3.90e-4 ✓ sig. |
| Gingival diseases | Hyaline fibromatosis | 0.125 | 1 | 4.55e-4 | 9.55e-4 ✓ sig. |
| Gingival diseases | Gingivitis | 0.125 | 1 | 4.55e-4 | 9.55e-4 ✓ sig. |
| Embryonal carcinoma | Gingival diseases | 0.111 | 1 | 9.09e-4 | 1.56e-3 ✓ sig. |
| Gingivitis | Hodgkin disease | 0.056 | 1 | 1.10e-3 | 1.81e-3 ✓ sig. |